Supplies Needed Peptide Vials (10 mg): 8 weeks ~3 vials 12 weeks ~6 vials Insulin Syringes (U-100): 7 per week 8 weeks 56 12 weeks 84 Bacteriostatic Water: 3 mL per vial 8 weeks ~9 mL 12 weeks ~18 mL Alcohol Swabs: 2 per day 8 weeks ~112 12 weeks ~168 Protocol Overview Goal: Support metabolic regulation and energy balance Schedule: Once-daily subcutaneous administration Dose Range: 2001000 mcg with gradual titration Cycle Length: 812 weeks (extendable to 16 weeks) Focus Areas: Insulin sensitivity, fat metabolism, endurance Dosing Protocol Start at 200 mcg daily (Weeks 12) Increase by ~200 mcg every 2 weeks Target 8001000 mcg daily Maintain consistent timing Rotate injection sites Storage Instructions Lyophilized: Store at 20C in a dry, dark environment Reconstituted: Refrigerate at 28C Avoid repeated freezethaw cycles Use within 23 weeks for best stability Allow vial to reach room temperature before opening Important Notes Key considerations for consistency, handling, and research accuracy

Recognizing these symptoms early prevents long-term complications
declares having received research funding (paid to institution) from Novo Nordisk, Sanofi, Mylan and Boehringer Ingelheim
Additionally, inflammation in the gut may disrupt communication between intestinal cells and the endocrine system, affecting hormones that regulate appetite and energy expenditure
Tirzepatide reduces hepatic fat content by 30-50% in most users within 6 months